(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
The Strait of Hormuz Isn’t Just an Oil Problem, It’s Now a Food Problem - 2From White Elephant to Favorite Things parties, here are all the rules you need to know every kind of gift exchange
- 3What to know about the "wild, wild West" of viral peptide claims
- 4From Iran to Israel: An Iranian volunteer’s unlikely stand in wartime
- 5Artemis moon mission breaks record for distance from Earth
- Don't plan to cook on Thanksgiving? Here are the restaurants and fast food places that are scheduled to be open
- How does Spotify Wrapped calculate your listening age? What your number says about you.
- Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- The Craft of Do-It-Yourself Home Stylistic layout: Change Your Space
- An eye for an eye: People agree about the values of body parts across cultures and eras
- Israel issues notice that Ben-Gurion Airport flights likely restricted until at least April 16
- Figure out How to Amplify the Resale Worth of Your Kona SUV
- Select Your Cherished Fish
- Instructions to Pick the Ideal Pre-assembled Home for Your Necessities
